No profile data available.
Opko Health, Inc. (OPK) is a healthcare company in the medical testing laboratories industry, based in Miami, United States, with about 2,275 full-time employees.
It reported revenue of $606.88 million for fiscal year 2025, down 14.9% from fiscal year 2024, and net income of -$225.68 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $163.58 million, up 4.3% from a year before. Its largest business segment, Diagnostics, brought in 61% of segment revenue in fiscal year 2025; United States was the largest region with 72%. Its market capitalization was $1.03 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics.
Opko Health reported $606.88 million in revenue for fiscal year 2025, down 14.9% from $713.14 million in fiscal year 2024. In Q2 2026 revenue was $163.58 million.
Diagnostics, with $370.28 million or 61% of segment revenue in fiscal year 2025. Next: Pharmaceutical (39%).
United States: 72% of revenue by region in fiscal year 2025, followed by Chile (10%).
$1.03 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (medical testing laboratories) include Labcorp Holdings Inc. (LH), GeneDx Holdings Corp. (WGS), NeoGenomics, Inc. (NEO), Fulgent Genetics, Inc. (FLGT).